相关产品推荐更多 >

Anti-Human HLA-DRA/DRB4 Antibody (8A), 抗人HLA-DRA/DRB4抗体 (8A)
¥1338
Anti-Mouse RLN1 Polyclonal Antibody, 抗小鼠RLN1多克隆抗体
¥1008
Anti-Human CLDN18.2 Antibody (SAA0137), FITC, 抗人CLDN18.2抗体 (SAA0137), FITC标记
询价
Anti-Bovine F9/Factor IX Polyclonal Antibody, 抗牛F9/Factor IX Polyclonal抗体
¥1008
Anti-Human ANXA13 Polyclonal Antibody, 抗人ANXA13 Polyclonal抗体
¥1008
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
AJE 润色服务限时 8 折起,权威机构信任 15+ 年Cytoscape 教程来了!快速实现顶刊同款通路网络图五大应用案例:Mustang Q 膜层析应用全解析1 个小工具,一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
/
- 亚型:
IgG2a, kappa
- 形态:
Liquid
- 保存条件:
0.01M PBS pH 7.4
- 克隆性:
Monoclonal
- 标记物:
Unconjugated
- 适应物种:
Human
- 保质期:
1 year
- 抗原来源:
Mouse
- 目录编号:
HV615013
- 级别:
科研级别
- 库存:
999
- 供应商:
abinScience
- 宿主:
Mouse
- 应用范围:
ELISA, In vivo Neutralization
- 浓度:
/
- 靶点:
C-C motif chemokine 17, CC chemokine TARC, CCL17, SCYA17, Small-inducible cytokine A17, TARC, Thymus and activation-regulated chemokine
- 抗体英文名:
Anti-Human CCL17/TARC Antibody (Iv0083)
- 抗体名:
Anti-Human CCL17/TARC Antibody (Iv0083)
- 规格:
/

| Product name | Anti-Human CCL17/TARC Antibody (Iv0083) |
|---|---|
| Catalog No. | HV615013 |
| Host species | Mouse |
| Species reactivity | Human |
| Immunogen | / |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Concentration | / |
| Purity | >95% as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG2a, kappa |
| Applications | ELISA, In vivo Neutralization |
| Target | C-C motif chemokine 17, CC chemokine TARC, CCL17, SCYA17, Small-inducible cytokine A17, TARC, Thymus and activation-regulated chemokine |
| References | / |
| Purification | Protein A/G purified from cell culture supernatant. |
| Biological activity | / |
| Endotoxin level | Please contact with the lab for this information. |
| Expression system | / |
| Accession | Q92583 |
| Label | / |
| Protein length | / |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Reconstitution | / |
| Detection method | / |
| Alternative Names | / |
| Clone ID | Iv0083 |
| Note | For research use only |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product research and development.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验); CSB-MP004843HU Recombinant Human C-C chemokine receptor type 4 (CCR4) (Active); CSB-CF004843HU ● CCR4 抗体 CCR4 Recombinant Monoclonal Antibody; CSB-RA004843MA01HU CCR4 Antibody; CSB-PA004843LA01HU 参考文献: [1] Kayoko Hase, K. Tani, Teruki
Introduction of human 14-3-3 proteins
of the tryptic peptides derived from the purified enzyme revealed two amino acid sequences homologous to the 14-3-3 proteins.A polyclonal antibody was raised against purified ST-IV.A 33 kDa protein was co-immunoprecipitated from rat brain extracts with the anti
of the tryptic peptides derived from the purified enzyme revealed two amino acid sequences homologous to the 14-3-3 proteins. A polyclonal antibody was raised against purified ST-IV. A 33 kDa protein was co-immunoprecipitated from rat brain extracts with the anti
技术资料暂无技术资料 索取技术资料





